Smokeless tobacco product snus may increase risk of death among prostate cancer patients

The smokeless tobacco product snus, which is used mainly in Sweden but also is sold in the U.S., may increase the risk that men with prostate cancer will die from their disease, and the risk that they’ll die prematurely from any cause, according to a new

The post Smokeless tobacco product snus may increase risk of death among prostate cancer patients appeared first on The Center.

Smoking Cessation Feeds